These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 29300962

  • 1. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
    Schlienz NJ, Cone EJ, Herrmann ES, Lembeck NA, Mitchell JM, Bigelow GE, Flegel R, LoDico CP, Hayes ED, Vandrey R.
    J Anal Toxicol; 2018 May 01; 42(4):232-247. PubMed ID: 29300962
    [Abstract] [Full Text] [Related]

  • 2. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
    Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R.
    J Anal Toxicol; 2020 Jan 07; 44(1):1-14. PubMed ID: 31095692
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
    Spindle TR, Cone EJ, Herrmann ES, Mitchell JM, Flegel R, LoDico C, Bigelow GE, Vandrey R.
    J Anal Toxicol; 2020 Oct 12; 44(7):661-671. PubMed ID: 32591782
    [Abstract] [Full Text] [Related]

  • 4. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ, Spindle TR, Cone EJ, Goffi E, Kuntz D, Mitchell JM, Winecker RE, Bigelow GE, Flegel RR, Vandrey R.
    J Anal Toxicol; 2022 May 20; 46(5):494-503. PubMed ID: 34089060
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA, Mitchell JM, Cone EJ.
    J Anal Toxicol; 1996 Oct 20; 20(6):441-52. PubMed ID: 8889681
    [Abstract] [Full Text] [Related]

  • 6. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.
    Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA.
    Clin Chem; 2003 Jul 20; 49(7):1114-24. PubMed ID: 12816908
    [Abstract] [Full Text] [Related]

  • 7. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
    Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA.
    J Anal Toxicol; 2004 Apr 20; 28(3):160-7. PubMed ID: 15107145
    [Abstract] [Full Text] [Related]

  • 8. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M.
    Anal Bioanal Chem; 2010 Apr 20; 396(7):2493-502. PubMed ID: 20112012
    [Abstract] [Full Text] [Related]

  • 9. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ.
    J Anal Toxicol; 2001 Apr 20; 25(5):289-303. PubMed ID: 11499881
    [Abstract] [Full Text] [Related]

  • 10. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
    Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):24-32. PubMed ID: 19631478
    [Abstract] [Full Text] [Related]

  • 11. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA, deWit H, Wachtel SR, Feng S, Murphy TP.
    J Anal Toxicol; 2001 Oct 01; 25(7):565-71. PubMed ID: 11599601
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the impact of hemp food consumption on workplace drug tests.
    Leson G, Pless P, Grotenhermen F, Kalant H, ElSohly MA.
    J Anal Toxicol; 2001 Oct 01; 25(8):691-8. PubMed ID: 11765026
    [Abstract] [Full Text] [Related]

  • 13. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ.
    J Anal Toxicol; 2001 Oct 01; 25(7):538-49. PubMed ID: 11599597
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
    Vandrey R, Herrmann ES, Mitchell JM, Bigelow GE, Flegel R, LoDico C, Cone EJ.
    J Anal Toxicol; 2017 Mar 01; 41(2):83-99. PubMed ID: 28158482
    [Abstract] [Full Text] [Related]

  • 15. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA.
    Clin Chem; 2011 Aug 01; 57(8):1127-36. PubMed ID: 21677094
    [Abstract] [Full Text] [Related]

  • 16. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
    Huestis MA, Mitchell JM, Cone EJ.
    J Anal Toxicol; 1995 Oct 01; 19(6):443-9. PubMed ID: 8926739
    [Abstract] [Full Text] [Related]

  • 17. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD, Worth D.
    Forensic Sci Int; 2003 Nov 26; 137(2-3):196-202. PubMed ID: 14609657
    [Abstract] [Full Text] [Related]

  • 18. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML.
    Ther Drug Monit; 2006 Aug 26; 28(4):540-4. PubMed ID: 16885722
    [Abstract] [Full Text] [Related]

  • 19. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
    Sholler DJ, Zamarripa CA, Spindle TR, Martin EL, Kuntz D, Vandrey R, Grabenauer M.
    J Anal Toxicol; 2022 Oct 14; 46(8):882-890. PubMed ID: 35770374
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML.
    Forensic Sci Int; 2007 Jul 04; 169(2-3):129-36. PubMed ID: 16963215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.